Financials
- Market Capitalization 14.55 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.42
市销率
3.49
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 4705 | TPST Tempest Therapeutics, Inc. - Common Stock | 1.02 USD | +4.08% | +3.03% | -18.40% | -57.32% | 15.10 M USD | ||
| 4711 | QNCX Quince Therapeutics, Inc. - Common Stock | 17.97 USD | -6.84% | +3.51% | +1853.26% | +938.73% | 14.65 M USD | ||
| 4715 | PASG Passage Bio, Inc. - Common Stock | 4.50 USD | +1.35% | -6.83% | -20.63% | -49.10% | 14.44 M USD | ||
| 4718 | AKTX Akari Therapeutics Plc - American Depositary Shares | 12.56 USD | -6.41% | -10.35% | -2.33% | +1041.82% | 14.38 M USD |